1. ALLA AKTIER
  2. NYHETER
  3. NEWBURY PHARMACEUTICALS

Newbury Pharmaceuticals

Nyheter Newbury Pharmaceuticals Nyheter alla bolag

Newbury to present at Redeye Growth Day 2023

On June 1st at 10:00 CEO, Lars Minor will discuss the latest developments in Newbury Pharmaceuticals at Redeye Growth Day 2023.

The In Focus interview is live broadcasted from Scandic Haymarket in Stockholm and can be followed at https://www.redeye.se/events/871323/redeye-growth-day

To get a preparatory introduction to Newbury Pharmaceuticals, please watch the Newbury Investor site for more information and recordings of company presentations https://www.newburypharma.com/investors/

A company presentation is also available at the Redeye event site with the possibility of posting questions https://www.redeye.se/video/company-prerecorded-presentation/911468/newbury-pharmaceuticals-3

For more information, contact:

Lars Minor, CEO
lars.minor@newburypharma.com
Mobile: +46 72-377 3005

www.newburypharma.com

About Newbury Pharmaceuticals

Newbury Pharmaceuticals is building a pipeline of proprietary and licensed products with focus on specialty and branded products in the Nordics. Newbury aims to make a difference by offering treatment solutions within areas like oncology, rare diseases and neurology. The portfolio is built by leveraging experience and extensive international network. Newbury offers strategic partnerships of innovation for the benefit of the Nordic healthcare market.

Västra Hamnen Corporate Finance is the Company's Certified Adviser on Nasdaq First North and can be reached at ca@vhcorp.se or +46 (0) 40 200 250.

Attachments

Newbury to present at Redeye Growth Day 2023

Datum 2023-05-25, kl 13:00
Källa MFN
Bifogade filer
Newbury to present at Redeye Growth Day 2023
Hej Serverägare! Har du problem med troll och spam? Nu finns möjligheten att sätta en liten avgift, t.ex. 20kr, på discord invites och därmed stoppa många återkommande troll samtidigt som du tjänar lite pengar. Kolla in Invite Paywall.